This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Reply to Letter to the Editor “Recommended Haloperidol and Risperidone Doses in First-Episode Psychosis”

Article Abstract

Letter to the Editor

Sir: I appreciate the opportunity to reply to Prof. McGorry’s letter regarding my article. Prof. McGorry expresses the concern that I may have recommended larger than necessary doses for risperidone and haloperidol in first-episode schizophrenia. He goes on to cite a study by McEvoy et al. demonstrating that haloperidol at 2.1 mg/day is effective in treating first-episode patients, as well as his own work suggesting that risperidone in the dosage range of 2 to 4 mg/day is effective in treating 60% of patients with first-episode psychosis. Prof. McGorry’s main point is that low doses of these 2 agents are necessary in order to avoid EPS and thus enhance patient compliance with treatment early in the course of illness.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders